Qsymia is a prescription weight-loss medication FDA-approved for chronic weight management in adults and adolescents aged 12 and older. It combines two active ingredients, phentermine and topiramate, into a single daily capsule. The drug is prescribed alongside a reduced-calorie diet and increased physical activity, not as a standalone treatment.
Who Qualifies for Qsymia
Qsymia isn’t available to anyone who wants to lose a few pounds. The FDA sets specific body mass index (BMI) thresholds for eligibility. Adults qualify if they have a BMI of 30 or higher, which falls in the obese range. Adults with a BMI of 27 or higher can also qualify, but only if they have at least one weight-related health condition such as high blood pressure, type 2 diabetes, or high cholesterol.
The FDA expanded approval to include adolescents aged 12 and older for chronic weight management, making Qsymia one of a limited number of weight-loss medications available to younger patients.
How Qsymia Works
The two ingredients in Qsymia attack appetite through different pathways. Phentermine is a stimulant-type appetite suppressant that reduces hunger signals. Topiramate, originally developed as a seizure medication, also decreases appetite and makes feelings of fullness last longer after meals. Together, they help people eat less without feeling as deprived as they would through willpower alone.
This dual approach is what distinguishes Qsymia from older single-ingredient diet pills. By targeting appetite from two directions, the combination tends to produce more weight loss than either ingredient would on its own.
What the Dosing Schedule Looks Like
Qsymia uses a gradual dose increase to minimize side effects. You start on the lowest dose for 14 days, then move up to a moderate maintenance dose for 12 weeks. At that point, your prescriber checks your progress.
If you haven’t lost at least 3% of your starting body weight after those 12 weeks, your dose may be increased over the next two weeks to the maximum strength. After another 12 weeks at the highest dose, if you still haven’t lost at least 5% of your body weight, the medication is typically discontinued. At that point, continued use is unlikely to produce meaningful results. Qsymia should not be stopped abruptly at higher doses; your prescriber will taper you off gradually.
Common Side Effects
The most frequently reported side effect is tingling or numbness in the hands and feet, a sensation known as paresthesia. This is a well-known effect of topiramate and is usually mild. Other common side effects include dry mouth, constipation, altered taste (foods may taste different or metallic), difficulty sleeping, and dizziness.
Some people experience trouble concentrating or feel mentally “foggy,” another effect tied to the topiramate component. These cognitive effects tend to be more noticeable at higher doses and often improve as the body adjusts. Increased heart rate is another possibility that prescribers monitor during treatment.
Who Should Not Take Qsymia
Several conditions rule out Qsymia entirely. It is contraindicated in pregnancy because topiramate can cause birth defects, particularly cleft lip and cleft palate. Women who could become pregnant must have a negative pregnancy test before starting and monthly during treatment, and they must use effective contraception consistently. If pregnancy occurs, the medication should be stopped immediately.
Qsymia is also off-limits for people with glaucoma, overactive thyroid (hyperthyroidism), or a known allergy to either ingredient. Anyone taking or who has recently stopped taking a type of antidepressant called an MAOI must wait at least 14 days before starting Qsymia, because the combination can trigger a dangerous spike in blood pressure.
Pregnancy Precautions
The pregnancy restrictions around Qsymia are unusually strict compared to most medications. The FDA requires a special safety program for this drug specifically because of the risk to a developing fetus. All women of reproductive potential, including those who believe they cannot get pregnant, are advised to use effective birth control throughout treatment. The only exceptions are women who have gone through menopause or have had surgical sterilization confirmed by their healthcare provider.
Monthly pregnancy testing is recommended for the entire duration of treatment. If you even suspect you might be pregnant, the guidance is to stop taking Qsymia right away and contact your prescriber, rather than waiting for confirmation.
How Weight Loss Progress Is Tracked
Qsymia uses built-in checkpoints to determine whether it’s working for you. The 3% threshold at 12 weeks on the moderate dose is the first decision point. Losing 3% of your body weight may not sound dramatic, but it signals that your body is responding to the medication and further loss is likely with continued use or a dose increase.
The 5% threshold at the maximum dose is the cutoff. If you reach it, treatment typically continues as long as the benefits outweigh the risks. Many people lose significantly more than these minimums. But if the drug hasn’t moved the needle by that 5% mark at the highest dose after 12 weeks, the evidence suggests it won’t start working later, and discontinuation is recommended. This structured approach helps avoid the common trap of staying on an ineffective medication indefinitely.